Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 20:38:12 GMT 2025
by
admin
on
Mon Mar 31 20:38:12 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Origin | MOUSE CHIMERIC |
| Sequence Type | COMPLETE |
| Record UNII |
T4H8FMA7IM
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C129822
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/07/508
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
||
|
FDA ORPHAN DRUG |
200505
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
||
|
FDA ORPHAN DRUG |
200605
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
SYLVANT (AUTHORIZED: GIANT LYMPH NODE HYPERPLASIA)
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
||
|
NCI_THESAURUS |
C20401
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
||
|
WHO-ATC |
L04AC11
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
||
|
NDF-RT |
N0000191006
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
T4H8FMA7IM
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
m11726
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
C61084
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
Siltuximab
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
541502-14-1
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
7396
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
WW-87
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
DB09036
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
SILTUXIMAB
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
CHEMBL1743070
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
SUB32552
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
T4H8FMA7IM
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
100000124530
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
1535218
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | RxNorm | ||
|
N0000191004
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | Interleukin-6 Antagonists [MoA] | ||
|
4977
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY | |||
|
9051
Created by
admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_146 | 1_202 |
| 1_263 | 1_323 |
| 1_369 | 1_427 |
| 2_22 | 2_96 |
| 2_146 | 2_202 |
| 2_263 | 2_323 |
| 2_369 | 2_427 |
| 3_23 | 3_87 |
| 3_133 | 3_193 |
| 4_23 | 4_87 |
| 4_133 | 4_193 |
| 1_222 | 3_213 |
| 2_222 | 4_213 |
| 1_228 | 2_228 |
| 1_231 | 2_231 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_299 |
| N | 2_299 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|